Global Florbetapir Market Projected to Reach USD 89 Million by 2026

19-Mar-2020 | Facts and Factors

 The global Florbetapir market in 2019 was approximately USD 69 Million. The market is expected to grow at a CAGR of 3.6% and is anticipated to reach around USD 89 Million by 2026.

Florbetapir Market Size,

Request Sample Request Customization Buy Now

Florbetapir is also known as florbetapir-fluorine-18 and is the trade name Amyvid. For the florbetapir F 18 injection, Avid and Lilly Received FDA’s complete response letter in March 2011. FDA approved Amyvid for its application in patients evaluated with cognitive decline especially Alzheimer's disease in April 2012. However, the EU Commission permitted the drug to use commercially in 2013.

Browse the full “Florbetapir Market By Type (30 mL Vial and 50 mL Vial) and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/florbetapir-market-by-type-30-ml-vial-and-828

The article is selected for Positron Emission Tomography (PET) imaging of beta-amyloid neuritic plaque concentration in the brain of grown-up patients with a subjective disability who are being assessed for causes of cognitive impairment. A positive Amyvid scan indicates the significant presence of amyloid plaques. The product has been strictly included in intravenous administration and is approved for only diagnostic use.

The rising prevalence of dementia is the chief reason behind the development of the florbetapir molecule. Dementia refers to a group of symptoms that comprises a failure in the ability to relate to others, reason, think, and remember. The symptoms can get worse over time until the person can no longer live independently and take care of themselves. Dementia has a social, physical, economic, and psychological impact on patients with dementia as well as on their families and society at large.

Robust research and development activities and investment in clinical trials are anticipated to fuel the product demand over the forecast period. Furthermore, major drivers fueling the growth of the market include the growing geriatric population and increasing per capita healthcare expenditure. Regulations for manufacturing and clinical trials are some of the key factors hindering the growth of the florbetapir market across the globe especially in the U.S. Some of the key trending factors of the global florbetapir market are increasing focus on a primary diagnosis of cognitive impairment diseases and rising prevalence of dementia.

Over the past few years, healthcare spending has increased significantly across the globe owing to enhanced purchasing power, preference for high-standard healthcare facilities and processes with growing awareness about early diagnosis and prevention.

The North American region accounted for 53% market share of total revenue generated in 2019. Alzheimer’s disease (AD) is the most common form of dementia in the U.S. which is estimated to affect 5.5 million individuals. As per Alzheimer’s Association, there are about 5.8 million people with the disease, and that this figure is set to rise to almost 14 million by 2050; additionally, it is the sixth principal reason for death.

5.4 million people in the EU currently have dementia and one in every 20 people over the age of 65 have AD, the most common form of dementia. Some of the projects include The European Prevention of Alzheimer’s Dementia (EPAD), Interdisciplinary Network for Dementia Utilizing Current Technology (INDUCT), and Amyloid imaging to prevent Alzheimer’s disease. According to the World Alzheimer Report 2010, costs associated with dementia for the Asia Pacific region have been estimated at USD 185 Billion. Around 70% of the total costs of dementia care were from advanced economies, which contain 18% of the prevalence. The Asia Pacific countries already have around half of the world’s population and the number of people living with dementia in the region will triple between now and 2050. There is an urgent need for governments to put in place policies and plans to ensure that adequate care and services are provided to people living with dementia in the future.

According to the World Alzheimer Report, in Latin America, the number of people with dementia is predicted to increase four-fold from 2015 to 2050. The World Health Organization stated 5.5% to 7% dementia prevalence with a standardized prevalence of 8.5%, although several Latin American countries are underrepresented in these statistics, and dementia prevalence may be underestimated.

Report Scope

Report Attribute

Details

Market Size in 2019

USD 69 Million

Projected Market Size in 2026

USD 89 Million

CAGR Growth Rate

3.6% CAGR

Base Year

2019

Forecast Years

2020-2026

Key Market Players

Eli Lilly, Navidea Biopharmaceuticals, Piramal Healthcare, GE Healthcare, and others.

Key Segment

By Type, By Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

This report segments the Florbetapir market as follows:

Global Florbetapir Market: By Type Segmentation Analysis

  • 30 mL Vial
  • 50 mL Vial

Global Florbetapir Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com

 


Latest Market Research Reports

report img

Organic Soap Market Report 2024 – 2032

[218+ Pages Report] According to Facts Factors, the global organic soap market size was worth around USD 2.1 billion in 2023 and is predicted to grow to around USD 4.3 billion by 2032, with a compound annual growth rate (CAGR) of roughly 8.3% between 2024 and 2032. Organic Soap Market: Overview Org

Published Date : 18-Nov-2024 | | Category : Consumer Goods | Pages : 218 | Format : Read more

Inquiry for Buying Request Sample
report img

Risk Management Software Market Report 2024 – 2032

[214+ Pages Report] According to Facts Factors, the global risk management software market size was valued at USD 9.64 billion in 2023 and is predicted to surpass USD 34.77 billion by the end of 2032. The risk management software industry is expected to grow by a CAGR of 14.36% between 2024 and 203

Published Date : 14-Nov-2024 | | Category : Software and Services | Pages : 214 | Format : Read more

Inquiry for Buying Request Sample
report img

Call Center AI Market Report 2024 – 2032

[213+ Pages Report] According to Facts Factors, the global call center AI market size was valued at USD 1.70 billion in 2023 and is predicted to surpass USD 11.19 billion by the end of 2032. The call center AI industry is expected to grow by a CAGR of 23.28% between 2024 and 2032. Call Center AI Ma

Published Date : 13-Nov-2024 | | Category : Technology & Media | Pages : 213 | Format : Read more

Inquiry for Buying Request Sample
report img

Personalized Nutrition Market Report 2024 – 2032

[221+ Pages Report] According to Facts Factors,the global personalized nutrition market size was valued at USD 13.35 billion in 2023 and is predicted to surpass USD 46.31 billion by the end of 2032. The personalized nutrition industry is expected to grow by a CAGR of 14.82% between 2024 and 2032. P

Published Date : 11-Nov-2024 | | Category : Healthcare | Pages : 221 | Format : Read more

Inquiry for Buying Request Sample
report img

Sleep Tech Devices Market Report 2024 – 2032

[218+ Pages Report] According to Facts Factors, the global sleep tech devices market size was valued at USD 20.68 billion in 2023 and is predicted to surpass USD 83.79 billion by the end of 2032. The sleep tech devices industry is expected to grow by a CAGR of 16.82% between 2024 and 2032. Sleep Te

Published Date : 08-Nov-2024 | | Category : Technology & Media | Pages : 218 | Format : Read more

Inquiry for Buying Request Sample

Why FnF Market Research?

1 Inflallible Methodology

to ensure high-level data integrity, accurate analysis, and impeccable forecasts

2 Analyst Support

for complete satisfaction

3 Customization

on-demand customization of scope of the report to exactly meet your needs

4 Targeted Market View

Targeted market view to provide pertinent information and save time of readers

5 Agile Approach

A faster and efficient way to cater to the needs with continuous iteration